Abstract Complexes of the type cis-[PdX 2 (imzt)(PPh 3 )] {imzt = imidazolidine-2-thione; PPh 3 = triphenylphosphine; X = Cl (1), Br (2), I (3), SCN (4)} have been synthesized and characterized by elemental analyses, molar conductance, IR and 1 H NMR spectroscopies. The complex 1ÁMeOH was obtained from the reaction of [PdCl 2 (CH 3-CN) 2 ], imidazolidine-2-thione and triphenylphosphine in CHCl 3 /CH 3 OH. Complexes 2ÁMeOH, 3 and 4 were prepared by metathesis of the chlorido ligands in 1 with bromide, iodide and thiocyanate, respectively. Elemental analyses showed good agreement with the expected mononuclear compositions, while the molar conductivities of the complexes in DMF were consistent with their nonelectrolytic nature. NMR spectra confirmed coordination of the imidazolidine-2-thione and triphenylphosphine ligands. Single-crystal X-ray diffraction determination of 1ÁCH 3 OH showed that the coordination geometry around Pd II is nearly square planar, with the chlorido ligands in a cis configuration. All four complexes have been tested in vitro by XTT assay for their cytotoxicity against human glioblastoma cell line (U87MG). The binding of 1 with guanosine was studied by 1 H NMR spectroscopy, revealing that the coordination takes place via N7.
Introduction
Gliomas are the most commonly occurring form of brain tumor. Particularly, glioblastoma multiforme (GBM) is the most malignant and severe type of brain tumor, with a high proliferation rate and low survival rates in comparison with all human cancers [1, 2] . Despite its limited success, temozolomide (TMZ) is the first line drug employed in the treatment of brain cancer [3] . Platinum compounds (cisplatin, carboplatin and oxaliplatin) are also used in association with TMZ to treat recurrent glioma [4] . Singleagent carboplatin/cisplatin has modest activity in patients with recurrent HGG previously treated with one line of chemotherapy, nitrosoureas or temozolomide [5] . However, their use has several limitations including nephrotoxicity, irreversible neurotoxicity and intrinsic/acquired resistance [6] . Therefore, the poor prognosis associated with these tumors together with limitations of current therapies has demanded intensive efforts to develop more effective drugs with lower toxicity and improved therapeutic properties.
In an effort to generate novel metal-based compounds that overcome the limitations associated with the use of platinum-based drugs in current clinical treatments, complexes containing different transition metals combined with a variety of ligand classes have been prepared and evaluated against cancer cell lines [7] . In this context, palladium(II) derivatives have emerged as potential alternative candidates for new metal antitumor drugs due to their structural and thermodynamic similarities to platinum(II) complexes [8] .
In this context, phosphine ligands have been widely employed to design new bioactive complexes. Many authors have proposed that the incorporation of phosphine ligands into palladium(II) complexes results in an increase of cytotoxicity by enhancing the lipid solubility of the complex, hence providing better membrane penetration [9] . In addition, the bulkiness of these ligands is expected to decrease the rate of associative substitution reactions, which may increase the kinetic stability of these complexes in biological media [9] . For instance, mononuclear organometallic compounds bearing diphosphines [PdN 3 (C-dmba)(dppp)] and [Pd(C 2 ,Ndmba)(dppet)](N 3 ) (dmba = N,N-dimethylbenzylamine; dppp = 1,3-bis(diphenylphosphino)propane; dppet = cis-1,2-bis(diphenylphosphino)ethylene) displayed promising cytotoxicity against glioblastoma C6 cell line, with IC 50 values less than 1 lM [10] .
In particular, compounds bearing the ''Pd(S)(PR 3 )'' core (S = sulfur-donor ligand; PR 3 = monodentate phosphine) exhibited promising cytotoxic effects toward some human cancer cell lines as well as some pathogenic microbes [11] . In this context, complexes with general formula [Pd(L) 2 (PPh 3 ) 2 ]Cl 2 and [Pd(L) 2 (PPh 3 ) 2 ] (L = thiourea or heterocyclic thioamide; PPh 3 = triphenylphosphine) were developed by Nadeem et al. [11] , and screened for cytotoxic activity with encouraging in vitro results against prostate cancer cells (PC3).
Motivated by the aforementioned observations, and as a part of our continuing research program in the field of coordination and biological chemistry of metal complexes [12] [13] [14] [15] [16] [17] [18] [19] , we present herein the synthesis and characterization of the complexes cis-[PdX 2 (imzt)(PPh 3 )] {imzt = imidazolidine-2-thione; PPh 3 = triphenylphosphine; X = Cl (1), Br (2), I (3), SCN (4)}, together with the effect of complexes 1-4 on the viability of U87MG human glioma cells.
Experimental Instrumental
C, H and N analyses were performed by the Central Analítica at IQ-University of São Paulo, on a Perkin Elmer 2400 series II instrument. Conductivities were measured with a Digimed-DM-31 conductometer using 1 9 10 -3 mol L (100 mg; 0.18 mmol) in MeOH (10 mL) was added KI (61 mg, 0.37 mmol) in water (1 mL). After stirring for 1 h, the suspension was filtered and the brown solid was washed with water, methanol and dried under vacuum. Yield 93%.
Dithiocyanato(imidazolidine-2-thione)(triphenylphosphine) palladium(II) (4): To a suspension of [PdCl 2 (imzt)(PPh 3 )] (100 mg; 0.18 mmol) in MeOH (10 mL) was added a solution of KNCS (36 mg, 0.37 mmol) in water (1 mL). After stirring for 1 h, the suspension was filtered and the yellow solid was washed with water, methanol and dried under vacuum. Yield 95%.
Single-crystal X-ray diffraction studies
Single crystals for X-ray crystallography of 1ÁMeOH were obtained by slow evaporation of a solution of the complex from chloroform/methanol 1:1. Data collection was performed on a BRUKER KAPPA APEX II DUO diffractometer using graphite-monochromated MoK a radiation (k = 0.71073 Å ) at 23°C. The multi-scan absorption correction method was employed. SHELXS and SHELXL software were used for structure solution and refinement [20] . The hydrogen atom positions were refined with fixed individual isotropic displacement parameters using a riding model, except those bonded to the nitrogen and oxygen atoms, which were located in the Fourier difference map and refined with isotropic temperature parameters. All non-hydrogen atoms positions were refined with anisotropic thermal displacements. Table 1 shows the crystallographic data and refinement conditions.
Cell culture and XTT assay
The U87MG human GBM (glioblastoma multiforme) cell line [American Type Culture Collection (ATCC) Ò HTB-14 TM ] was obtained from the ATCC (American Type Culture Collection, Manassas, VA, USA). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) Ham's F-10 (Sigma-Aldrich; Merck Millipore), supplemented with 10% fetal bovine serum (FBS; Cultilab, Campinas, Brazil) and 1% penicillin (10.000 units)/streptomycin (10 mg) (Sigma-Aldrich; Merck Millipore). Cells were incubated at 37°C in an atmosphere containing 5% CO 2 until they reached semi-confluence, when they were used for proliferation experiments.
Test solutions of the compounds (1000 lM) were freshly prepared by dissolution in 50 lL of DMSO and completed with 4950 lL of culture medium. These stock solutions were diluted in culture medium to reach final concentrations of 100, 50.0, 25.0, 12.5 e 6.25 lM. The DMSO solvent in the concentrations used did not reveal any cytotoxic activity compared to the untreated control. The average of how much DMSO interfered with the proliferation in comparison with the untreated control was 106.4 ± 22.3%.
For proliferation assay, GBM cells (5000 cells for 24 h and 500 cells for 120 h) were seeded in 96 well plates, cultured for 24 h and treated with the test compounds and the solvent control (DMSO) for 24 h. After PBS 19 washing, complete medium was added and cells were cultured for 24 or 120 h. After this incubation time, the medium was removed and cells were washed with PBS 19. Cells were incubated for 2 h at 37°C with 100 lL per well of a solution of XTT (sodium 3 0 -[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis(4-methoxy-6-nitro)benzene sulfonic acid hydrate) assay-Cell Proliferation Kit II-XTT, Roche Molecular Biochemicals) and DMEM without 
Reaction with guanosine
The reaction with guanosine was carried out using the procedure described by Rocha et al. [16] , with some modifications. (4) , agreeing well with their expected mononuclear compositions (Table 2) .
Crystal structure of complex 1
The crystal structure of 1ÁMeOH has been determined by single-crystal X-ray diffraction, and its ORTEP representation with the atom labeling scheme is illustrated in Fig. 1 . Selected interatomic bond distances and angles with their estimated standard deviations are shown in Table 3 .
Complex 1 crystallizes in the monoclinic space group P2 1 /c, with the asymmetric unit being constituted by one complex molecule and one methanol solvate molecule. The palladium(II) center is coordinated by two cis-positioned chlorido ligands, one imidazolidine-2-thione and one triphenylphosphine ligand (Fig. 1) . The observed cis configuration is the expected result of the mutual destabilizing effects of phosphorus and sulfur ligands in trans positions when coordinated to a class b metal center (antisymbiotic effect) [22] . The geometry around Pd II is essentially square planar, with interatomic bond angles that deviate slightly from 90°(S1-Pd1-Cl2 = 92.80(2)°, P1-Pd1-Cl1 = 92.06 (2)°, Cl1-Pd1-Cl2 = 89.43(2)°, S1-Pd1-P1 = 85.88(2)°). The Pd1-Cl1 and Pd1-Cl2 bond lengths agree well with those observed in other Pd II compounds [17] . Nevertheless, the two Pd-Cl bond distances were found to be distinct: The shorter Pd1-Cl1 (2.3026(5) Å ) is located trans to the S1 atom, whereas the longer Pd1-Cl2 (2.3958(5) Å ) is trans to the P1 atom. This finding is associated with the different trans influences of the triphenylphosphine and imidazolidine-2-thione ligands. The Pd1-S1 (2.3169(5) Å ) and Pd1-P1 (2.2554(5) Å ) distances are comparable to those found in the complex cis-[PdCl 2 (tu)(PPh 3 )] (tu = thiourea) [17] at 2.3191(1) and 2.2440(1) Å , respectively.
Upon coordination, modifications of the bond distances of the thiourea moiety in the imidazolidine-2-thione ligand are observed. According to crystallographic studies on free imidazolidine-2-thione [23] , the CS and CN bonds are 1.692(1) and 1.328 (mean) Å . The significant lengthening (3), respectively) clearly indicates changes in the electron density distribution. Hence the CS bond is weakened, while the p-bond character of the CN bonds is strengthened upon complexation. Such behavior has already been observed in other metal-based complexes of imidazolidine-thiones [24] .
The crystal packing is stabilized by several hydrogen bonds (see Table S5 , Sup. Mat.) in which the NH groups of imzt take part in intramolecular and intermolecular interactions of the type N(2)-H(2)ÁÁÁCl (2) 
Spectroscopic studies
The most significant IR data for free imzt and its palladium(II) complexes 1-4 are summarized in Table 4 . IR spectroscopy is one of the most widely used spectroscopic techniques to assign the coordination mode of imidazolidine-2-thione ligands. According to Wheatley [25] , the electronic structure of imidazolidine-2-thione may be denoted by a hybrid of three canonical forms (I, II and III), as shown in Scheme 2.
The IR spectrum of imidazolidine-2-thione has been reported previously, and key absorption bands have been assigned [26] . In principle, imzt can coordinate through both sulfur and nitrogen atoms. Upon S-coordination, the contribution of the structures II and III will be enhanced, leading to weakening of the CS bond. According to Dwarakanath and Sathyanarayana [26] , the bands at 516 and 925 cm -1 in free imzt possess considerable mC=S contribution. Thus, the shift of these absorptions to lower frequency on coordination is characteristic of the Scoordination mode. On the other hand, the mCN band (1509 cm -1 in free imzt) shifts to higher frequencies because of the greater double bond character of the CN bond on S-coordination. In the present case, the coordination of imzt via the thione sulfur is suggested by the shift to higher frequency of the mCN band from 1509 cm -1 to ca. 1535 cm -1 (1-4), while the thione group band is red shifted from 925 cm -1 to ca. 915 cm -1 (1-4) . The other band with the highest mCS contribution was masked by the strong absorptions of triphenylphosphine over the 520-400 cm -1 spectral range [16, 27] . The coordination of neutral imzt in 1-4 is clearly evidenced by the presence of intense mNH absorptions between 3380 and 3120 cm -1 . In particular, the IR spectra of the halidocomplexes 1-3 share a common feature in this spectral range; the presence of a sharp band at *3363 cm -1 and two overlapped absorptions at ca. 3180 and 3130 cm -1 . This is attributed to involvement of the imzt NH groups in different types of hydrogen bonding [28] . The similar patterns observed for the mNH bands suggest that the complexes 1-3 have closely related structures. The IR spectrum of complex 4 exhibits a single broad mNH absorption at 3180 cm -1 , indicating that the polynuclear nature of the anionic ligand gives rise to a distinct hydrogen bonding network. For complex 4, the observation of a relatively broad and intense m as SCN band at 2104 cm -1 supports the terminal N-bonded coordination mode for the thiocyanato ligand [29] . The presence of methanol solvate in 1 and 2 was detected by a typical mOH absorption at ca. 3448 cm -1 . The low solubilities of the complexes were sufficient for their conductivity values and 1 H NMR spectra to be measured, but their 13 C NMR spectra could not be recorded. The insolubility of complex 3 in all common deuterated solvents hindered us from obtaining its NMR spectrum. However, 1 H NMR spectroscopy also unequivocally allowed assignment of the S-coordination mode of the imzt ligand in complexes 1, 2 and 4. Chemical shifts and assignment are summarized in Table 5 .
Significant shifts are observed for the NH and -CH 2 -resonances in the complexes. The NH resonance changed from 7.95 ppm (free imzt) to ca. 8.8 ppm (complexes), whereas the -CH 2 -signal was displaced by ca. 0.4 ppm to downfield. This shift is assigned to the delocalization of pelectrons between N atoms as a consequence of the greater double bond character of the CN bond, as well as the weakening of the CS bond on complex formation [30] . Such spectroscopic behavior agrees well with the crystallographic results for complex 1, which showed changes in the bond lengths of the ''HNC(S)NH'' moiety upon complexation. In addition, the presence of an N-H signal in the 1 H NMR spectra indicated that the imzt ligands are coordinated in the thione form in solution [31] . Integration of the proton signals was in accordance with the requirements for 1, 2 and 4. A signal at 3.15 ppm in the spectra of 1 and 2 is attributed to the methyl group of the MeOH molecule. In agreement with the analytical and spectroscopic data together with the crystallographic results on complex 1, a proposal for the structures of the analogous compounds 2ÁMeOH, 3 and 4 has been suggested, in which the metal center is coordinated to two anions {bromido (2ÁMeOH), iodido (3) or N-thiocyanato (4)}, one imidazolidine-2-thione ligand, and one triphenylphosphine ligand in a cis configuration (Scheme 1).
Cytotoxic activities against human glioblastoma
The cytotoxic activities of the free PPh 3 , imzt and the palladium(II) complexes have been evaluated against human glioblastoma cell line (U87MG). Cells were exposed to a range of Pd II complex concentrations (100, 50, 25, 12.5 and 6.25 lM) for 24 h (Fig. 2) and 120 h (Fig. 3) .
As shown in Fig. 2 , after 24 h of incubation, concentrations of 10-50 lM of all four complexes did not modify the viability of the U87MG cell line. However, the number of viable cells for complex 1 was reduced to 50% at 69.65 ± 1.04 lM, while complexes 2 and 4 were much less active in this concentration. Complex 3 was considered to be inactive at all tested concentrations.
After 120 h of exposure (Fig. 3) , complex 1 exhibited the highest cytotoxic effect (IC 50 = 56.01 ± 1.06 lM), Table 6 .
Complex 1 reduced the viability of U87MG tumor cells over time at concentrations as low as 100 lM. This effect was observed within 24 h of treatment and persisted for over 120 h. It is important to emphasize that complex 1 was much more active against U87MG tumor cells than temozolomide (TMZ), the first line drug employed in the treatment of brain cancer [32] . After 24 h of exposure, TMZ had not demonstrated any cytotoxic effect, even at high drug concentrations (1000 lM). On the other hand, 120 h of exposure was sufficient to reduce to 50% the number of viable cells at 200 lM of TMZ [32] . These findings indicate that complex 1 is more active than TMZ in vitro after 24 and 120 h incubation times.
The cytotoxicity data reveal an interesting trend, in that the cytotoxicity level of the complexes decreased according to the anionic ligand X, following the order Cl [ Br & SCN ) I, which implies that the lability of the Pd-X bond may be playing a key role in determining the activities of these compounds. Taking into account that the free ligands are inactive, the mode of action of the most active chlorido-complex may involve the initial transportation of [PdCl 2 (imzt)(PPh 3 )] into the tumor cells, followed by reaction (of the complex or one of its hydrolysis products) at the active sites. In line with this hypothesis, it is wellestablished that cis-dichlorido Pd(II) complexes interact with DNA in an analogous manner to their Pt(II) counterparts [18] . Hence, in order to gain more knowledge about its reactivity toward DNA, we have evaluated the ability of complex 1 to bind to guanosine, a model for a purine base.
Interaction of complex 1 with guanosine
It is well known that the antitumor activity of various platinum-based pharmaceuticals is associated with their platination of DNA, most commonly through binding to guanine. Similarly to cisplatin, some palladium(II) compounds can also coordinate to N7 of guanine [33] . We have therefore selected guanosine as a purine model system to study the reactivity of complex 1 by means of 1 H NMR spectroscopy.
The reaction between guanosine and 1 was initially studied in DMSO because of the low solubility of the [32] complex in aqueous media. However, complex 1 did not react with guanosine after 48 h under such conditions. Therefore, to enhance reactivity, chlorido abstraction of 1 by silver nitrate in DMSO was undertaken, affording a reactive nitrato/solvento complex in situ. Thus, a solution of complex 1 in DMSO-d 6 was left to react for 1 h with two equivalents of AgNO 3 , then the insoluble AgCl was eliminated by centrifugation. The resulting yellow solution was mixed with guanosine (2.0 eq.) and left to stand for 48 h before being analyzed by 1 H NMR spectroscopy. Under these conditions, the nitrato/solvento complex reacted with guanosine, yielding an adduct with molar ratio 1:2 palladium(II)-guanosine. A downfield shift (0.41 ppm) of the signal attributed to the H8 atom from guanosine (Fig. 4) is characteristic of metal coordination via N7 [34] (Scheme 3).
We conclude that complex 1 is capable of interacting with guanosine only after the removal of its chlorido ligands by AgNO 3 . It is important to point out that the limited reactivity of 1 with guanosine is not enough to rule out the involvement of DNA as a molecular target. Nevertheless, there is a growing body of evidence that suggests that palladium(II) compounds exert their activity by different mechanisms than those observed for classical platinum(II) complexes. In this context, Rocha et al. [12] reported that complexes of the type [PdX(PPh 3 )(4-MeT)]X {PPh 3 = triphenylphosphine;
4-MeT = 4-methyl-3-thiosemicarbazide; X = Cl, Br, I, SCN} displayed a scarce reactivity toward DNA, but were capable of inhibiting human topoisomerase IIa and cathepsin B at a micromolar concentration range. Another interesting example involving a phosphine-based palladium(II) complex was described by Gigli et al. [35] . In this work, the death of melanoma cells induced by [Pd 2 (S (-) C 2 ,N-dmpa) 2 (ldppf)Cl 2 ]
(dmpa = N,N-dimethyl-1-phenethylamine; dppf = 1,2-bis(diphenylphosphino)ferrocene) involved the lysosomal-mitochondrial axis, being characterized by lysosomal membrane permeabilization, cathepsin B activation and increased Bax protein levels following its translocation to mitochondria [35] . In addition, some palladium(II) compounds, in contrast to their platinum(II) analogs, have been found to be non-mutagenic in the Ames test [19] .
Conclusions
In conclusion, we have successfully prepared and characterized four new palladium(II) complexes. All four complexes are assigned a cis configuration, as a result of the antisymbiotic effects of the triphenylphosphine and imidazolidine-2-thione ligands. In all four complexes, the imzt acts as an S-monodentate ligand. The fact that complex 1 displayed higher cytotoxicity than its analogs suggests that changing halido or pseudohalido ligands (X) exerts an effect on the cytotoxicity of this class of compounds. Currently ongoing studies in our laboratories are aiming at rationalizing the cytotoxicity in terms of structure-activity relationships. 
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